| Literature DB >> 25281485 |
Xue-Hai Guan1, Qiao-Chu Fu1, Dai Shi1, Hui-Lian Bu1, Zhen-Peng Song1, Bing-Rui Xiong1, Bin Shu1, Hong-Bing Xiang1, Bing Xu2, Anne Manyande3, Fei Cao4, Yu-Ke Tian5.
Abstract
Previously, we showed that activation of the spinal CXCL9, 10/CXCR3 pathway mediated bone cancer pain (BCP) in rats. However, the cellular mechanism involved is poorly understood. Here, we found that the activated CXCR3 was co-localized with either neurons, microglia, and astrocytes in the spinal cord, or non-peptidergic-, peptidergic-, and A-type neurons in the dorsal root ganglion. The inoculation of Walker-256 mammary gland carcinoma cells into the rat's tibia induced a time-dependent phosphorylation of Akt and extracellular signal-regulated kinase (ERK1/2) in the spinal cord, and CXCR3 was necessary for the phosphorylation of Akt and ERK 1/2. Meanwhile, CXCR3 was co-localized with either pAkt or pERK1/2. Blockage of either Akt or ERK1/2 prevented or reversed the mechanical allodynia in BCP rats. Furthermore, there was cross-activation between PI3K/Akt and Raf/MEK/ERK pathway under the BCP condition. Our results demonstrated that the activation of spinal chemokine receptor CXCR3 mediated BCP through Akt and ERK 1/2 kinase, and also indicated a crosstalk between PI3K/Akt and Raf/MEK/ERK signaling pathways under the BCP condition. CrownEntities:
Keywords: Akt; Bone cancer; CXCR3; ERK; Pain
Mesh:
Substances:
Year: 2014 PMID: 25281485 DOI: 10.1016/j.expneurol.2014.09.019
Source DB: PubMed Journal: Exp Neurol ISSN: 0014-4886 Impact factor: 5.330